This inventor holds 1 USPTO granted patent. Top assignee: Wisconsin Alumni Research Foundation. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Angela R. Jones: Innovator in Blood-Brain Barrier Targeting Antibodies
Introduction
Angela R. Jones is a notable inventor based in College Park, MD (US). She has made significant contributions to the field of biomedical research, particularly in the development of antibodies that target the blood-brain barrier (BBB). Her innovative work aims to enhance the delivery of therapeutic agents to the brain, which is crucial for treating various neurological disorders.
Latest Patents
Angela R. Jones holds a patent for a BBB-selective antibody. This application discloses a BBB-selective antibody that comprises a protein encoded by specific DNA sequences. These sequences include SEQ ID NO:7 (CDRH1 of scFv 15), SEQ ID NO:8 (CDRH2 of scFv 15), SEQ ID NO:9 (CDRH3 of scFv 15), SEQ ID NO:10 (CDRL1 of scFv 15), SEQ ID NO:11 (CDRL2 of scFv 15), and SEQ ID NO:12 (CDRL3 of scFv 15). The antibody may also comprise proteins encoded by SEQ ID NO:19 through SEQ ID NO:24, which correspond to another variant of the antibody. This innovative approach has the potential to revolutionize treatments for conditions affecting the brain.
Career Highlights
Angela R. Jones is affiliated with the Wisconsin Alumni Research Foundation, where she continues to advance her research in antibody development. Her work is characterized by a commitment to improving therapeutic strategies for neurological diseases. With her expertise, she has positioned herself as a key figure in the field of biomedical innovation.
Collaborations
Angela has collaborated with esteemed colleagues, including Eric V. Shusta and Charles C. Stutz. These partnerships have fostered a collaborative environment that enhances the research and development of groundbreaking biomedical solutions.
Conclusion
Angela R. Jones exemplifies the spirit of innovation in the field of biomedical research. Her work on blood-brain barrier targeting antibodies represents a significant advancement in therapeutic delivery systems. Through her contributions, she is paving the way for new treatments that could improve the lives of many individuals suffering from neurological disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile